ReShape Lifesciences, Inc. - Common Stock (NQ:RSLS)

3.920 UNCHANGED

Last Price Updated: 4:00 PM EDT, Aug 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ReShape Lifesciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

October 25, 2023

Pre-market stock movers are a hot topic on Wednesday and we're offering all the details that investors need to know about this morning.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 24, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 13, 2023

Via Benzinga

Earnings Outlook For Reshape Lifesciences ↗

August 04, 2023

Via Benzinga

Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

October 13, 2023

Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.

Via Benzinga

Why Comtech Telecommunications Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

October 13, 2023

Gainers Oblong, Inc. (NASDAQ: OBLG) shares rose 295.7% to $1.16 in pre-market trading.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 12, 2023

Via Benzinga

Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

October 12, 2023

Gainers

Via Benzinga

Why BSQUARE Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket ↗

October 12, 2023

Gainers OpGen, Inc. (NASDAQ: OPGN) shares rose 432% to $1.79 in pre-market trading. Opgen said on Oct. 6, unit Curetis GMBH received payment of 750,000 euros related to the sale of certain Unyvero A50...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 12, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

October 12, 2023

Pre-market stock movers are a hot topic among traders on Thursday and we're offering all of the latest coverage this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 11, 2023

Via Benzinga

Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 02, 2023

Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares climbed 86.1% to $0.2248 after the company said it is considering strategic alternatives for its non-core operations.

Via Benzinga

Why AERWINS Technologies Shares Are Trading Higher By Around 90%; Here Are 20 Stocks Moving Premarket ↗

October 02, 2023

Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares rose 90.2% to $0.2297 in pre-market trading. Aerwins Technologies is considering strategic alternatives for non-core operations including, not...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 29, 2023

Friday's session saw 112 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 29, 2023

Via Benzinga

ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering

September 29, 2023

From ReShape Lifesciences Inc

Via GlobeNewswire

Why Glimpse Group Shares Are Trading Lower By Around 41%; Here Are 20 Stocks Moving Premarket ↗

September 29, 2023

Gainers RVL Pharmaceuticals plc (NASDAQ: RVLP) shares rose 181.8% to $0.2201 in pre-market trading.

Via Benzinga

ReShape Lifesciences® Announces Participation in the LD Micro Main Event XVI

September 22, 2023

From ReShape Lifesciences Inc

Via GlobeNewswire

ReShape Lifesciences® Signs Exclusive License Agreement With Biorad Medisys for Obalon® Gastric Balloon System

September 21, 2023

Royalty-Bearing License Agreement Covers the Countries in the Indian Subcontinent, Representing Approximately 20% to 25% of the World’s Population

From ReShape Lifesciences Inc

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Tuesday ↗

September 19, 2023

During Tuesday's session, 275 companies made new 52-week lows.

Via Benzinga

ReShape Lifesciences® Significantly Strengthens Patent Portfolio Related to its Obalon® Balloon System

September 19, 2023

Granted One Patent from USPTO and Receives Two Notices of Allowance, Providing Foundational Protection

From ReShape Lifesciences Inc

Via GlobeNewswire

ReShape Lifesciences® Receives NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation™ Device

September 14, 2023

$331,541 Grant will Explore the use of High-Resolution Endoscopic Ultrasound to Aid in the Placement of the DBSN™ Device

From ReShape Lifesciences Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 06, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 28, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 23, 2023

Via Benzinga

ReShape Lifesciences® Reports Second Quarter Ended June 30, 2023 Financial Results and Provides Corporate Update

August 07, 2023

From ReShape Lifesciences Inc

Via GlobeNewswire

ReShape Lifesciences® to Announce Financial Results for the Second Quarter Ended June 30, 2023 and Provide Corporate Update

August 03, 2023

Conference Call to be Held at 5:00 pm ET on Monday, August 7, 2023

From ReShape Lifesciences Inc

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 01, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.